These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. MDMA (3,4-methylendioxymetamphetamine) conference held at the Brain Sciences Institute, Swinburne University, Melbourne, on 11-13th September 2008. Preface. Parrott AC Neuropsychobiology; 2009; 60(3-4):117-8. PubMed ID: 19893328 [No Abstract] [Full Text] [Related]
26. Early loss of two renal grafts obtained from the same donor: role of ecstasy? McIntyre JA; Wagenknecht DR Transplantation; 2006 Jul; 82(1):140; author reply 140-1. PubMed ID: 16861956 [No Abstract] [Full Text] [Related]
27. MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective. Parrott AC; Marsden CA J Psychopharmacol; 2006 Mar; 20(2):143-6. PubMed ID: 16510473 [No Abstract] [Full Text] [Related]
28. Role of dantrolene in treatment of heat stroke associated with Ecstasy ingestion. Duffy MR; Ferguson C Br J Anaesth; 2007 Jan; 98(1):148-9. PubMed ID: 17158133 [No Abstract] [Full Text] [Related]
29. "Ecstasy" and neurotoxic effects on the brain. Gamma A Toxicol Lett; 2003 Jan; 136(3):229-30; author reply 231-2. PubMed ID: 12569927 [No Abstract] [Full Text] [Related]
30. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Fonsart J; Menet MC; Declèves X; Galons H; Crété D; Debray M; Scherrmann JM; Noble F Toxicol Appl Pharmacol; 2008 Jul; 230(1):117-25. PubMed ID: 18358511 [TBL] [Abstract][Full Text] [Related]
31. Morphological effects in the mouse myocardium after methylenedioxymethamphetamine administration combined with loud noise exposure. Gesi M; Lenzi P; Soldani P; Ferrucci M; Giusiani A; Fornai F; Paparelli A Anat Rec; 2002 May; 267(1):37-46. PubMed ID: 11984790 [TBL] [Abstract][Full Text] [Related]
33. [Metabolites of ecstasy and cytotoxicity effects]. Fleury MB; Neudörffer A; Felim A; Blanco M; Monnet FP; Largeron M Ann Pharm Fr; 2009 Mar; 67(2):91-6. PubMed ID: 19298892 [TBL] [Abstract][Full Text] [Related]
34. Drug use and risk behaviour among regular ecstasy users: Does sexuality make a difference? Degenhardt L Cult Health Sex; 2005; 7(6):599-614. PubMed ID: 16864225 [TBL] [Abstract][Full Text] [Related]
36. Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury. Warren MW; Kobeissy FH; Liu MC; Hayes RL; Gold MS; Wang KK J Addict Dis; 2006; 25(4):115-23. PubMed ID: 17088231 [TBL] [Abstract][Full Text] [Related]
37. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. Carhart-Harris RL; Nutt DJ; Munafò M; Wilson SJ J Psychopharmacol; 2009 May; 23(3):249-57. PubMed ID: 18562419 [TBL] [Abstract][Full Text] [Related]
38. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy"). Cohen RS Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525 [No Abstract] [Full Text] [Related]
39. [Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')]. de Man RA; Wilson JH; Tjen HS Ned Tijdschr Geneeskd; 1993 Apr; 137(14):727-9. PubMed ID: 8097286 [TBL] [Abstract][Full Text] [Related]